A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...

Good day and welcome to the FibroGen third-quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded. I would now like to hand the call over to David ...

Merck & Co (MSD), Alexion, and AstraZeneca Rare Disease have reported positive topline outcomes from the Phase III KOMET ...

A European Union court upheld the bloc's decision to approve Vodafone's acquisition of some of Liberty Global's telecommunications assets, thwarting a legal challenge from German telecom rivals.